Tonghua Golden-Horse Pharmaceutical Industry Co., Ltd.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Mar'26 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Mar 2026 is 1.56% vs -0.03% in Mar 2025",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Mar 2026 is -21.55% vs 26.09% in Mar 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "300.10",
          "val2": "295.50",
          "chgp": "1.56%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "29.50",
          "val2": "48.50",
          "chgp": "-39.18%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "20.80",
          "val2": "20.00",
          "chgp": "4.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "-0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "9.10",
          "val2": "11.60",
          "chgp": "-21.55%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "98.40%",
          "val2": "109.60%",
          "chgp": "-1.12%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2025 is -11.72% vs -10.50% in Dec 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2025 is -38.93% vs 29.63% in Dec 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1,158.90",
          "val2": "1,312.70",
          "chgp": "-11.72%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "172.30",
          "val2": "202.90",
          "chgp": "-15.08%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "82.50",
          "val2": "82.80",
          "chgp": "-0.36%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-0.20",
          "val2": "0.30",
          "chgp": "-166.67%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "34.20",
          "val2": "56.00",
          "chgp": "-38.93%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "94.40%",
          "val2": "103.20%",
          "chgp": "-0.88%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Mar'26 - YoY

Mar'26

Mar'25

Change(%)

Net Sales

300.10

295.50

1.56%

Operating Profit (PBDIT) excl Other Income

29.50

48.50

-39.18%

Interest

20.80

20.00

4.00%

Exceptional Items

0.00

-0.00

Consolidate Net Profit

9.10

11.60

-21.55%

Operating Profit Margin (Excl OI)

98.40%

109.60%

-1.12%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in quarter ended Mar 2026 is 1.56% vs -0.03% in Mar 2025

Consolidated Net Profit

YoY Growth in quarter ended Mar 2026 is -21.55% vs 26.09% in Mar 2025

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'25

Dec'25

Dec'24

Change(%)

Net Sales

1,158.90

1,312.70

-11.72%

Operating Profit (PBDIT) excl Other Income

172.30

202.90

-15.08%

Interest

82.50

82.80

-0.36%

Exceptional Items

-0.20

0.30

-166.67%

Consolidate Net Profit

34.20

56.00

-38.93%

Operating Profit Margin (Excl OI)

94.40%

103.20%

-0.88%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2025 is -11.72% vs -10.50% in Dec 2024

Consolidated Net Profit

YoY Growth in year ended Dec 2025 is -38.93% vs 29.63% in Dec 2024

All Annual Results